The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases
Abstract
The present review provides a summary of recent evidence of sortilin expression, function, and regulation and its implications in lipid metabolism and development of lipid disorder diseases. As a member of the vacuolar protein sorting 10 protein (Vps10p) receptor family, sortilin mediates intracellular trafficking of diverse endogenous or exogenous protein substrates between the trans-Golgi network (TGN) and plasma membrane compartments. Recent studies reveal that sortilin regulates the expression of lipid genes, plasma lipid level, and the development of lipid disorder diseases. Sortilin promotes atherogenesis by regulating hepatic very low density lipoprotein (VLDL) secretion and plasma lipid level and subsequently macrophage lipid accumulation. Sortilin deficiency is caused by accelerated proteasome degradation under insulin resistance conditions and is thereby implicated in the hyperlipidemia of type 2 diabetes mellitus (T2DM). Sortilin facilitates hepatic cholesterol accumulation by inhibiting hepatic cholesterol catabolism, which promotes the development of nonalcoholic fatty liver disease (NAFLD). Sortilin plays an important role in lipid metabolism and represents a promising therapeutic target for lipid disorder diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hepatocyte sortilin modulates very low density lipoprotein (VLDL) secretion.
“In addition to facilitating PCSK9 secretion, hepatocyte sortilin has been shown to modulate very low density lipoprotein (VLDL) secretion;66–70”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [70]
Citations
Cites
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Nielsen, M. S., Madsen, P., Christensen, E. I., Nykjær, A., Gliemann, J., Kasper, D., Pohlmann, R., & Petersen, C. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2180 · Cited by 457
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Strong, A., Ding, Q., Edmondson, A. C., Millar, J. S., Sachs, K. V., Li, X., Kumaravel, A., Wang, M. Y., Ai, D., Guo, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63563 · Cited by 222
Macrophage Sortilin Promotes LDL Uptake, Foam Cell Formation, and Atherosclerosis
Patel, K. M., Strong, A., Tohyama, J., Jin, X., Morales, C. R., Billheimer, J., Millar, J., Kruth, H., & Rader, D. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.305811 · Cited by 194
The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion
Gustafsen, C., Kjolby, M., Nyegaard, M., Mattheisen, M., Lundhede, J., Buttenschøn, H., Mors, O., Bentzon, J. F., Madsen, P., Nykjaer, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.006 · Cited by 170
Identification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism
Lu, X., Meima, M. E., Nelson, J. K., Sorrentino, V., Loregger, A., Scheij, S., Dekkers, D. H. W., Mulder, M. T., Demmers, J. A. A., M-Dallinga-Thie, G., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.306799 · Cited by 48
Flagged first, then by citations
Research works printed but not linked: 91
- 10.1172/JCI61248 · DOI
- 10.1016/j.jjcc.2014.02.012 · DOI
- 10.1161/CIRCRESAHA.115.306361 · DOI · Paper page
- 10.1002/jmv.24367 · DOI
- 10.1194/jlr.M046524 · DOI
- 10.1186/s12860-016-0085-9 · DOI
- 10.1371/journal.pone.0084969 · DOI
- 10.1016/j.ajhg.2010.11.002 · DOI · Paper page
- 10.1210/jc.2015-3940 · DOI
- 10.1152/ajpgi.00472.2005 · DOI
- Chow M.D., 2017, Mol Aspects Med, 17, 1
- 10.1097/MOL.0000000000000175 · DOI
- 10.1055/s-0033-1358519 · DOI
- 10.1161/CIRCGENETICS.114.000534 · DOI
- 10.1111/j.1600-0854.2009.01017.x · DOI
- 10.1091/mbc.12.2.475 · DOI
- 10.1091/mbc.02-07-0105 · DOI
- 10.1074/jbc.M112295200 · DOI
- 10.1002/bies.201100003 · DOI
- 10.1001/jamacardio.2016.0096 · DOI
- 10.2165/11590330-000000000-00000 · DOI
- Fisher E., 2014, J Biomed Res, 28, 178, 10.7555/JBR.28.20140019 · DOI
- 10.1155/2011/783976 · DOI
- Gibbons G.F., 2002, J R Soc Med, 95, 23
- 10.1161/ATVBAHA.116.308932 · DOI
- 10.1016/j.atherosclerosis.2016.06.011 · DOI
- 10.1172/JCI80851 · DOI
- 10.4238/2015.August.7.18 · DOI
- 10.1016/j.ihj.2015.05.020 · DOI
- Haas M.E., 2013, TEM, 24, 391
- 10.1007/s004390100504 · DOI
- 10.1007/s00018-009-0043-1 · DOI
- 10.1016/j.ijcard.2016.11.064 · DOI
- 10.1016/j.arteri.2015.11.001 · DOI
- 10.1099/mic.0.28627-0 · DOI
- 10.3724/SP.J.1005.2013.00830 · DOI
- 10.1038/jid.2010.187 · DOI
- 10.1007/s11883-015-0496-7 · DOI
- 10.1016/j.cmet.2010.08.006 · DOI · Paper page
- Kleber M.E., 2010, The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis, 209, 492
- 10.2169/internalmedicine.56.7796 · DOI
- 10.1093/cvr/cvw094 · DOI
- 10.1210/jc.2009-0141 · DOI · Paper page
- 10.3109/10409238.2011.562481 · DOI
- 10.1210/en.2003-0288 · DOI
- 10.1074/jbc.M115.641225 · DOI
- 10.1074/jbc.M114.548933 · DOI
- 10.1074/jbc.M116.762005 · DOI
- 10.1016/j.atherosclerosis.2009.06.034 · DOI · Paper page
- 10.1172/JCI76002 · DOI
- 10.18632/oncotarget.5098 · DOI
- 10.1093/emboj/18.3.595 · DOI
- 10.1016/j.atherosclerosis.2016.03.041 · DOI
- 10.1038/ncomms6068 · DOI
- 10.1002/pro.2512 · DOI
- 10.1016/j.jhep.2014.08.030 · DOI
- 10.1161/01.HYP.22.1.56 · DOI
- 10.1016/j.jsbmb.2017.02.013 · DOI
- 10.1155/2015/678924 · DOI
- 10.1186/s12933-016-0412-7 · DOI
- 10.1080/00325481.2016.1208895 · DOI
- 10.1007/s00109-008-0387-2 · DOI
- 10.1016/j.atherosclerosis.2015.11.027 · DOI
- 10.1016/j.yjmcc.2015.04.004 · DOI
- 10.1097/MOL.0000000000000244 · DOI
- 10.1016/j.bbrc.2015.11.068 · DOI
- 10.1016/j.bbrc.2016.07.096 · DOI · Paper page
- 10.1007/s11883-012-0248-x · DOI
- 10.1097/MOL.0000000000000110 · DOI
- 10.1161/CIRCRESAHA.115.306256 · DOI · Paper page
- 10.1074/jbc.M106737200 · DOI
- 10.2174/1566524053766086 · DOI · Paper page
- 10.1038/nature09270 · DOI · Paper page
- 10.1097/CRD.0000000000000008 · DOI
- 10.3892/mmr.2015.3472 · DOI
- 10.1038/srep29332 · DOI
- 10.1111/j.1469-1809.2011.00646.x · DOI
- 10.1016/j.tiv.2016.08.011 · DOI
- 10.1074/jbc.M408873200 · DOI
- 10.1038/ng.76 · DOI · Paper page
- 10.1097/MOL.0b013e328350fad2 · DOI
- 10.1097/MOL.0b013e3283416f2b · DOI
- 10.1038/nrn2516 · DOI
- 10.1080/19420889.2015.1130192 · DOI
- 10.1002/hep.26714 · DOI
- 10.1097/WNR.0b013e3283619f43 · DOI
- 10.7150/ijbs.14027 · DOI
- 10.1194/jlr.M800277-JLR200 · DOI
- 10.1016/j.ijcard.2013.11.093 · DOI
- 10.1016/j.cca.2016.06.013 · DOI
- Zhou Y.J., 2015, Int J Clin Exp Pathol, 8, 9543
Cited by
Sorted by citations
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29
Self-citation
Metadata
- Authors
- Gao, A., Cayabyab, F. S., Chen, X., Yang, J., Wang, L., Peng, T., & Lv, Y.
- Affiliations
- Clinical Anatomy & Reproductive Medicine Application Institute, University of South China, Hengyang, China.
- Department of Surgery, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
- Department of Metabolism & Endocrinology, The First Affiliated Hospital, University of South China, Hengyang, China.
- Venue
- DNA and Cell Biology
- Publisher
- SAGE Publications
- Published
- 2017-12
- Volume
- 36
- Issue
- 12
- Pages
- 1050-1061
- ISSN
- 1044-5498
- 1557-7430
- Cited by
- 43
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review